Literature DB >> 21605280

Serum KL-6 and surfactant protein D in children with 2009 pandemic H1N1 influenza infection.

Satoko Nishida1, Ryuji Fukazawa, Takehide Imai, Sachiyo Takeda, Jun Hayakawa, Hodaka Takeuchi, Kiwako Shimizu, Yasuhiko Kawakami, Masato Takase.   

Abstract

BACKGROUND: A global pandemic influenza A (H1N1) outbreak occurred in 2009. Rapid progress of respiratory distress is one of the characteristic features of pandemic influenza A (H1N1) infection. The physiologic mechanism causing hypoxia in pandemic influenza A (H1N1) infection, however, has not been elucidated.
METHODS: The serum levels of KL-6 and surfactant protein D (SP-D) were evaluated in 21 cases of pandemic influenza A (H1N1) infection associated with chest radiographic abnormality in order to estimate alveolar involvement. The clinical features were also analyzed.
RESULTS: All of the patients had high fever, and rapidly progressed to respiratory distress within several days of disease onset. Despite mild radiographic abnormality in these patients, dyspnea was severe and they had low blood oxygen saturation levels. Many of the patients had a history of allergic diseases including asthma. Serum KL-6 and SP-D levels on admission were 191 ± 69 U/mL and 32.6 ± 18.9 ng/mL, respectively. These two levels were still below the upper normal limit 1 week later. There were no clear relationships between specific clinical symptoms and KL-6 or SP-D levels. All patients were treated with oseltamivir and/or zanamivir, and improved without mechanical ventilation management.
CONCLUSION: KL-6 and SP-D elevation were not significant in pandemic influenza A (H1N1) infection associated with chest radiographic abnormality. In pandemic influenza A (H1N1) infection, alveolar involvement was estimated to be little, and severe respiratory distress was probably caused by obstruction of peripheral bronchi.
© 2011 The Authors. Pediatrics International © 2011 Japan Pediatric Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21605280     DOI: 10.1111/j.1442-200X.2011.03398.x

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  4 in total

1.  Factors influencing the measurement of plasma/serum surfactant protein D levels by ELISA.

Authors:  Preston E Bratcher; Amit Gaggar
Journal:  PLoS One       Date:  2014-11-03       Impact factor: 3.240

2.  Analysis of Early Biomarkers Associated with the Development of Critical Respiratory Failure in Coronavirus Disease 2019 (COVID-19).

Authors:  Hiroyoshi Yamada; Masaki Okamoto; Yoji Nagasaki; Suzuyo Yoshio; Takashi Nouno; Chiyo Yano; Tomohiro Tanaka; Fumi Watanabe; Natsuko Shibata; Yoko Arimizu; Yukako Fukamachi; Yoshiaki Zaizen; Naoki Hamada; Atsushi Kawaguchi; Tomoaki Hoshino; Shigeki Morita
Journal:  Diagnostics (Basel)       Date:  2022-01-28

3.  Pulmonary surfactants and the respiratory-renal connection in steroid-sensitive nephrotic syndrome of childhood.

Authors:  Gabriel Cara-Fuentes; Ana Andres-Hernando; Colin Bauer; Mindy Banks; Gabriela E Garcia; Christina Cicerchi; Masanari Kuwabara; Michiko Shimada; Richard J Johnson; Miguel A Lanaspa
Journal:  iScience       Date:  2022-06-30

4.  Serum surfactant protein D (SP-D) is a prognostic marker of poor outcome in patients with A/H1N1 virus infection.

Authors:  Carlos Delgado; Edgar Krötzsch; Luis A Jiménez-Alvarez; Gustavo Ramírez-Martínez; Jose E Márquez-García; Alfredo Cruz-Lagunas; Juan Morán; Cármen Hernández; Patricia Sierra-Vargas; Federico Avila-Moreno; Carina Becerril; Martha Montaño; José L Bañales-Méndez; Joaquín Zúñiga; Ivette Buendía-Roldán
Journal:  Lung       Date:  2014-12-24       Impact factor: 2.584

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.